Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers

Published:2015-05 Issue:5 Volume:103 Page:1305-1312
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Perri Tamar,Lifshitz Dror,Sadetzki Siegal,Oberman Bernice,Meirow Dror,Ben-Baruch Gilad,Friedman Eitan,Korach Jacob

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference53 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2013

2. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2;King;Science,2003

3. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

4. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population;Simchoni;Proc Natl Acad Sci U S A,2006

5. Ovarian cancer: etiology, risk factors, and epidemiology;Hunn;Clin Obstet Gynecol,2012

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer;Journal of Cancer Research and Clinical Oncology;2024-09-11

2. Fertility drugs and cancer: a guideline;Fertility and Sterility;2024-09

3. Social and psychological aspects of medical and genetic counseling of patients with hereditary tumor syndromes and their relatives;2024-08-24

4. The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-07-17

5. Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?;ESMO Open;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3